TechBloomberg Tech2h ago
Mindrank AI CEO on Business Strategy, AI Drug Discovery
TL;DRAI biotech startup Mindrank uses machine learning to accelerate drug discovery.
Why it matters: AI-driven drug development could significantly reduce discovery timelines and costs in pharma.
Niu Zhangming, Founder and CEO at AI biotech firm Mindrank AI, discusses the company's business strategy and the role of AI in drug discovery. He speaks with Minmin Low on the sidelines of the Asia Innovation and Technology Enterprises Going Global Summit in Hong Kong. (Source:…
Read full articleSource: Bloomberg Tech · Opens in new tab